IZEA vs REGN · rev $35.9M vs P/E 14, rev $14.34B
IZEA Inc (IZEA) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
IZEA Inc (IZEA) is a internet content & information company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported IZEA revenue for 2024-12-31 was $35.9M. Net income was -$18.9M. Revenue was down 0.9% from 2023-12-31 to 2024-12-31. IZEA currently screens at market cap $65.5M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
IZEA currently screens at market cap $65.5M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the IZEA and REGN stock pages for the full models.
Not investment advice.